The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I study evaluating the pharmacokinetics of components of S-1 in pts with varying degrees of renal function.
M. W. Saif
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
M. Lichinitser
No relevant relationships to disclose
M. S. Gordon
Research Funding - Taiho Pharmaceutical
B. R. Tan
No relevant relationships to disclose
M. E. Scheulen
No relevant relationships to disclose
N. B. Pandya
No relevant relationships to disclose
J. Sarantopoulos
Research Funding - Taiho Pharmaceutical
J. J. Rinehart
No relevant relationships to disclose
C. F. Verschraegen
Research Funding - Taiho Pharmaceutical
H. Lenz
Research Funding - Taiho Pharmaceutical
C. Zergebel
Employment or Leadership Position - Taiho Pharmaceutical
K. Saito
Employment or Leadership Position - Taiho Pharmaceutical